R Paul Edick
Affiliations
- See Remarks at Xeris Biopharma Holdings Inc. (XERS), 2024-01-31
- Chief Executive Officer at Xeris Pharmaceuticals Inc (XERS), 2021-10-05
- Director at Milestone Pharmaceuticals Inc. (MIST), 2020-06-08
- Director at Iterum Therapeutics Plc (ITRM), 2019-05-29
- Director at Pdl Biopharma Inc. (PDLI), 2018-06-12
- Director at Sucampo Pharmaceuticals Inc. (SCMP), 2018-02-13
- Director at Neos Therapeutics Inc. (NEOS), 2017-07-05
- Director at Newlink Genetics Corp ((NLNK)), 2017-05-16
- Chief Executive Officer at Durata Therapeutics Inc. (DRTX), 2014-11-18
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| XERS | $2.38 | 10,000 | $23,794.00 | 2,288,064 | 2023-08-09 | Filing |
| XERS | $1.45 | 20,000 | $29,000.00 | 1,528,064 | 2022-12-13 | Filing |
| XERS | $1.40 | 100,000 | $140,380.00 | 1,508,064 | 2022-05-12 | Filing |
| XERS | $2.28 | 20,000 | $45,664.00 | 33,430 | 2021-11-15 | Filing |
| XERS | $2.08 | 200,000 | $415,760.00 | 808,064 | 2021-11-11 | Filing |